Platinum chemotherapy utilization declined by 15.1% at the height of the national shortage. The shortage did not translate to an increase in short-term mortality. The shortage of generic ...

The leading Extensive-Stage Small Cell Lung Cancer Companies such as Shanghai Henlius Biotech, MacroGenics, Inc., RayzeBio, ...

Background: Small cell bladder cancer (SCBC) is a rare aggressive bladder cancer (BC) variant comprising <1% of BC. Recommended front line etoposide and platinum chemotherapy for SCBC is extrapolated ...

Gilead reports Q4 earnings on Feb. 11. Analysts expect $1.70 EPS. The LEO Pharma deal could reduce 2025 EPS by up to $0.17.

2-Year U.S. Treasury Note Continuous Contract $102.781-0.031-0.03% 5-Year U.S. Treasury Note Continuous Contract $106.375-0.016-0.01% 10-Year U.S. Treasury Note Continuous Contract $108.875 0.031 ...

The effects of chemotherapy can continue after treatment ... These symptoms are most commonly reported in people who take platinum compounds (like oxaliplatin) and taxanes (like docetaxel).

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

two chemotherapy drugs are commonly prescribed, one of which would include either cisplatin or carboplatin (known as the "platinum drugs"). For advanced NSCLC, only one chemo drug may be used, ...

Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced multiple oral and poster presentations, ...

USC is resistant to cytotoxic chemotherapy and is responsible for most recurrences and deaths from endometrial cancer. USC has a unique gene expression profile. Molecular markers can aid in ...